The rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the German company set to make $7.6 billion from the sale. The divestment will make Elanco the ...

Bayer has delayed a planned sale of its animal health unit to private equity interests in order to explore a merger with US firm Elanco, claims Reuters. Citing three separate anonymous sources ...

In a regulatory filing, Elanco (ELAN) disclosed that its director David Hoover bought 25K shares of common stock on March 5th in a total transaction size of $272.6K. See what stocks are receiving ...

As of December 31, 2024, Elanco's net leverage ratio was 4.3x adjusted EBITDA, flat to September 30, 2024. The company anticipates a headwind to revenue of approximately $110 million from the ...

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as ...

In this article, we are going to take a look at where Elanco Animal Health Incorporated (NYSE:ELAN) stands against the other stocks. Ten firms ended Tuesday suffering a sell-off, as investor ...

Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for. Elanco missed analysts’ revenue expectations by 0.6% last ...

Animal health company Elanco (NYSE:ELAN) reported Q4 CY2024 results exceeding the market’s revenue expectations , but sales fell by 1.4% year on year to $1.02 billion. On the other hand, ...